tiprankstipranks
Greenwich Lifesciences, Inc. (GLSI)
:GLSI
US Market

Greenwich LifeSciences (GLSI) Income Statement

Compare
375 Followers

Greenwich LifeSciences Income Statement

Last quarter (Q3 2024), Greenwich LifeSciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Greenwich LifeSciences's net income was $-2.67M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.61K$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Expenses
$ 9.33M$ 8.04M$ 4.60M$ 1.86M$ 3.43M
Depreciation and Amortization
$ 3.61K$ 3.61K$ 3.61K$ 3.61K$ 3.61K
EBITDA
$ -9.32M$ -8.04M$ -4.59M$ -1.86M$ -3.42M
Operating Income
$ -9.33M$ -8.04M$ -4.60M$ -1.86M$ -3.43M
Other Income/Expenses
$ 436.06K$ 215.02K$ 27.37K$ 832.00$ 0.00
Pretax Income
$ -8.89M$ -7.83M$ -4.57M$ -1.86M$ -3.43M
Net Income
$ -8.89M$ -7.61M$ -4.54M$ -1.86M$ -3.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.69$ -0.59$ -0.35$ -0.15$ -0.29
Diluted EPS
$ -0.69$ -0.59$ -0.35$ -0.15$ -0.29
Weighted Average Shares Outstanding
12.85M 12.91M 12.94M 12.70M 11.74M
Weighted Average Shares Outstanding (Diluted)
12.85M 12.91M 12.94M 12.70M 11.74M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis